Clinical Trial Detail

NCT ID NCT01878617
Title A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

medulloblastoma

Therapies

Vismodegib

Cisplatin + Cyclophosphamide + Vincristine Sulfate

Gemcitabine + Pemetrexed Disodium

Age Groups: adult child

No variant requirements are available.